Top Markets
Coin of the day
TaiRx, Inc. TaiRx, Inc.

TaiRx, Inc.

6580
शेयरों में रैंक #25842
TaiRx, Inc., established in 2011 and headquartered in Taipei City, Taiwan, is a... TaiRx, Inc., established in 2011 and headquartered in Taipei City, Taiwan, is a pharmaceutical company dedicated to the research, development, and commercialization of therapeutic solutions for cancer and other diseases. The company's clinical pipeline includes CVM-1118, an oral anti-cancer drug currently undergoing Phase II clinical trials, and Rexis, an add-on injection therapy for sepsis patients, which is in Phase III trials. In its pre-clinical stage, TaiRx is developing TRX-711 for secondary hyperparathyroidism, TRX-920 as an oral delivery formulation, and TRX-105, a molecule designed to treat and alleviate symptoms of various types of colitis. Beyond its developmental drugs, TaiRx also offers Zelnite, a medication that helps maintain patients' blood selenium levels and supports their immune systems. The company's future endeavors also involve the development of nodal diagnostic devices and innovative antibody-based drugs.
शेयर मूल्य
$0.40861751
मार्केट कैप
$45.81M
बदलाव (1 दिन)
-1.15%
बदलाव (1 वर्ष)
-46.41%
देश
TW
व्यापार TaiRx, Inc. (6580)

श्रेणी

TaiRx, Inc. (6580) के लिए डिविडेंड यील्ड इतिहास
TaiRx, Inc. (स्टॉक सिंबल: 6580) की डिविडेंड यील्ड (TTM) 2026 को: 0
पिछले 5 वर्षों की औसत डिविडेंड यील्ड: 0.00%
TaiRx, Inc. (6580) के लिए 2026 से 2026 तक की डिविडेंड यील्ड का इतिहास
प्रत्येक वर्ष के अंत में डिविडेंड यील्ड (TTM)
वर्ष डिविडेंड यील्ड परिवर्तन
प्रदान की गई तारीखों के लिए पर्याप्त डेटा नहीं।
समान कंपनियों या प्रतिस्पर्धियों के लिए डिविडेंड यील्ड (TTM)
कंपनी डिविडेंड यील्ड देश
0.00%
US
0.00%
NL
3.12%
AU
0.00%
CH
0.00%
US